(Q52828506)

8 May 2018

title

Inhibition of growth of two human pancreatic adenocarcinomas in vivo by somatostatin analog SMS 201-995. (English)

1 reference

8 May 2018

0 references

1 reference

C M Townsend

1 reference

8 May 2018

author name string

J R Upp

1 reference

8 May 2018

D Olson

1 reference

8 May 2018

G J Poston

1 reference

8 May 2018

R W Alexander

1 reference

8 May 2018

J C Thompson

1 reference

8 May 2018

language of work or name

English

0 references

publication date

1 January 1988

1 reference

8 May 2018

The American Journal of Surgery

published in

1 reference

8 May 2018

volume

155

1 reference

8 May 2018

issue

1 reference

8 May 2018

page(s)

29-35

1 reference

8 May 2018

describes a project that uses

CAV

0 references

cites work

Combined effect of chronic bombesin and secretin or cholecystokinin on the rat pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Inhibitory Effect of Prolonged Administration of Long-Acting Somatostatin on Gastrin-Stimulated Fundic Epithelial Cell Growth in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Effects of chronic administration of somatostatin on rat exocrine pancreas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Growth factors and intestinal neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Regression of metastatic vipoma with somatostatin analogue SMS 201-995

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth, and gastro-entero-pancreatic hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Role of insulin secretagogues in the regulation of somatostatin binding by isolated rat islets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Somatostatin binding sites in cytosolic fraction isolated from rabbit antral and fundic gastric mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Somatostatin: Mechanism of Action in Pancreatic Islet β-Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Caerulein and secretin induced pancreatic growth: a possible control by endogenous pancreatic somatostatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

Gastrointestinal hormones and gastrointestinal and pancreatic carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

inferred from DOI database lookup

7 January 2021

based on heuristic

A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9610%2888%2980254-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9610(88)80254-X

1 reference

8 May 2018

1 reference

8 May 2018